
Derivados de Purinas e Pirimidinas
As purinas possuem uma estrutura bicíclica, formada por um anel de seis membros fundido a um anel de cinco membros, ambos contendo átomos de nitrogênio em posições-chave. Os derivados das purinas, como a adenina e a guanina, são essenciais para a formação do DNA e RNA. Estes compostos possuem aplicações terapêuticas no tratamento do câncer e de doenças virais, pois inibem a replicação celular. As pirimidinas, por outro lado, possuem uma estrutura monocíclica de seis membros com dois átomos de nitrogênio. Seus derivados, como citosina, timina e uracila, também são componentes essenciais do DNA e RNA e são utilizados na quimioterapia e em tratamentos antivirais.
Na CymitQuimica, oferecemos derivados de purinas e pirimidinas para pesquisa em biologia molecular, genômica e desenvolvimento de terapias inovadoras.
Foram encontrados 8881 produtos de "Derivados de Purinas e Pirimidinas"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Sodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate
CAS:Pureza:95.0%Cor e Forma:SolidPeso molecular:391.18701171875(S)-Methyl-L-thiocitrulline.Dihydrochloride
CAS:<p>M02076 - (S)-Methyl-L-thiocitrulline.Dihydrochloride</p>Fórmula:C7H17Cl2N3O2SPureza:>98%Peso molecular:278.194-(4-Pyrimidin-4-yl-1H-pyrazol-1-yl)benzoic acid
CAS:Pureza:95.0%Cor e Forma:SolidPeso molecular:266.260009765625Orphenadrine Citrate
CAS:<p>Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoi</p>Fórmula:C18H23NO·C6H8O7Cor e Forma:White Crystalline PowderPeso molecular:269.17796Caffeine Related Compound F (1,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione)
CAS:<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Fórmula:C7H8N4O2Cor e Forma:White Fine PowderPeso molecular:180.06473Pemetrexed Acid N-Hydroxysuccinimide Ester (2,5-dioxopyrrolidin-1-yl 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoate)
CAS:<p>Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoi</p>Fórmula:C19H17N5O5Cor e Forma:White Off-White SolidPeso molecular:395.12297Pemetrexed Disodium Enantiomer ((2R)-2-[[4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid, sodium salt)
CAS:<p>Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoi</p>Fórmula:C20H19N5O6NaCor e Forma:Pale Green SolidPeso molecular:576.5Ondansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride)
CAS:<p>Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi</p>Fórmula:C16H20N2O·HClCor e Forma:White SolidPeso molecular:256.15756Theophylline
CAS:<p>Theophylline and aminophylline (excluding fenetylline) and their derivatives, salts thereof, not elsewhere specified or included</p>Fórmula:C7H8N4O2Cor e Forma:White PowderPeso molecular:180.17 g/molCaffeine
CAS:<p>Caffeine and its salts</p>Fórmula:C8H10N4O2Cor e Forma:White Crystalline Powder NeedlesPeso molecular:194.08038Aspirin
CAS:<p>Ortho-acetylsalicylic acid (aspirin), its salts and esters</p>Fórmula:C9H8O4Cor e Forma:White Colorless SolidPeso molecular:180.04226Acetaminophen
CAS:<p>Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereof</p>Fórmula:C8H9NO2Cor e Forma:White PowderPeso molecular:151.06333Imidazole (1H-Imidazole)
CAS:<p>Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoi</p>Fórmula:C3H4N2Cor e Forma:White Light Yellow Crystalline PowderPeso molecular:68.03745Methylbenzhydrol (2-Methylbenzhydrol)
CAS:<p>Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoi</p>Fórmula:C14H14OCor e Forma:White PowderPeso molecular:198.10447Ondansetron Related Compound D (1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one)
CAS:<p>Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoi</p>Fórmula:C14H13NOCor e Forma:White Off-White PowderPeso molecular:211.09971Ondansetron Related Compound C (9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one)
CAS:<p>Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi</p>Fórmula:C13H13NOCor e Forma:White Powder ClumpyPeso molecular:199.09971Pemetrexed Dimethyl Ester (dimethyl (4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoyl)-L-glutamate)
CAS:<p>Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoi</p>Fórmula:C22H25N5O6Cor e Forma:Off-White SolidPeso molecular:455.18048Febuxostat
CAS:<p>Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure</p>Fórmula:C16H16N2O3SCor e Forma:White Off-White PowderPeso molecular:316.08816Pemetrexed Acid (4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoic acid)
CAS:<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Fórmula:C15H14N4O3Cor e Forma:Off-White SolidPeso molecular:298.10659Febuxostat Related Compound C (Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate)
CAS:<p>Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure</p>Fórmula:C14H12N2O3SCor e Forma:Off-White Fine PowderPeso molecular:288.05686Ondansetron Resolution Mixture
<p>Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoi</p>Cor e Forma:Off-White White PowderCaffeine Related Compound C (1,3,9-Trimethyl-3,9-dihydro-1H-purine-2,6-dione)
CAS:<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Fórmula:C8H10N4O2Cor e Forma:White Fine PowderPeso molecular:194.08038Ondansetron Hydrochloride
CAS:<p>Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoi</p>Fórmula:C18H19N3O·HCl·2H2OCor e Forma:White Off-White PowderPeso molecular:293.15281Pemetrexed Sodium 1-Methyl Ester ((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-5-methoxy-5-oxopentanoic acid, sodium salt)
CAS:<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Fórmula:C21H22N5O6·NaCor e Forma:White Off-White SolidPeso molecular:440.15701Allopurinol Related Compound E (Ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate)
CAS:<p>Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoi</p>Fórmula:C7H9N3O3Cor e Forma:White Off-White PowderPeso molecular:183.06439Allopurinol Related Compound D (Ethyl 5-amino-1H-pyrazole-4-carboxylate)
CAS:<p>Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure nesoi</p>Fórmula:C6H9N3O2Cor e Forma:White Light Yellow Crystalline PowderPeso molecular:155.06948Ondansetron
CAS:<p>Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoi</p>Fórmula:C18H19N3OCor e Forma:White Off-White PowderPeso molecular:293.15281Clopidogrel Related Compound C (methyl (-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Fórmula:C16H16ClNO2S·H2SO4Cor e Forma:White PowderPeso molecular:321.05903Tetrahydrothienopyridine Hydrochloride (4,5,6,7-Tetrahydrothieno[3,2-c]pyridine, hydrochloride)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Fórmula:C7H9NS·HClCor e Forma:Off-White SolidPeso molecular:139.04557Clopidogrel Thienopyridinium Chloride (5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)thieno[3,2-c]pyridin-5-ium, chloride)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Fórmula:C16H13ClNO2S·ClCor e Forma:Off-White SolidPeso molecular:318.03555Clopidogrel Diester Enantiomer Sulfate ((S)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl (R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate, sulfate)
<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Fórmula:C24H21Cl2NO4S·H2SO4Cor e Forma:White Off-White SolidPeso molecular:489.05683Methyl 2-chloro-β-D-phenylalanine (methyl (R)-2-amino-2-(2-chlorophenyl)acetate, hydrochloride)
CAS:<p>Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, nesoi</p>Fórmula:C9H10ClNO2·HClCor e Forma:White Off-White SolidPeso molecular:235.01668Clopidogrel Ethyl Ester Sulfate (ethyl (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate, sulfate)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Fórmula:C17H18ClNO2S·H2O4SCor e Forma:White Off-White SolidPeso molecular:335.07468Clopidogrel Acid N-Oxide (5-((S)-carboxy(2-chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Fórmula:C15H14ClNO3SCor e Forma:White Off-White SolidPeso molecular:323.03829Clopidogrel Open Ring Hydrochloride (methyl (S)-2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino) acetate, hydrochloride)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Fórmula:C15H16ClNO2S·HClCor e Forma:White Off-White SolidPeso molecular:346.272-Oxo Clopidogrel (Mixture of Diastereomers) (methyl 2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Fórmula:C16H16ClNO3SCor e Forma:Off-White SolidPeso molecular:337.053942-Oxo R-Clopidogrel (methyl (2R)-2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Fórmula:C16H16ClNO3SCor e Forma:White Off-White SolidPeso molecular:337.05394Clopidogrel Bisulfate
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Fórmula:C16H16ClNO2S·H2SO4Cor e Forma:White Off-White PowderPeso molecular:321.05903Allopurinol Related Compound B (5-(formylamino)-1H-pyrazole-4-carboxamide)
CAS:<p>Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoi</p>Fórmula:C5H6N4O2Cor e Forma:White PowderPeso molecular:154.04908(R)-Clopidogrel Carboxylic Acid ((R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Fórmula:C15H14ClNO2SCor e Forma:Off-White SolidPeso molecular:307.04338Clopidogrel N-Oxide (5-((S)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Fórmula:C16H16ClNO3SCor e Forma:Pale Yellow SolidPeso molecular:337.05394Allopurinol
CAS:<p>Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure</p>Fórmula:C5H4N4OCor e Forma:White PowderPeso molecular:136.03851Allopurinol Related Compound C (5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide)
CAS:<p>Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoi</p>Fórmula:C6H6N6OCor e Forma:White Off-White Crystalline PowderPeso molecular:178.06031Triacetin
CAS:<p>Esters of acetic acid not elsewhere specified or included</p>Fórmula:C9H14O6Cor e Forma:Colorless Oily LiquidPeso molecular:218.21



